FTSE 250 movers: Puretech Health rallies; Computacenter says no
FTSE 250 (MCX) 20,798.44 -0.43%
Puretech Health rallied as it hailed promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as "extremely exciting".
Johnson Matthey gained as its largest investor, Standard Investments, called for a strategic review of the business which could include its sale.
Computacenter was weaker after it announced the immediate departure of Christian Jehle as its chief financial officer and an executive director by mutual agreement, with his responsibilities temporarily managed by the finance team and executive management until a successor is appointed.
Russ Mould said: "There is no explanation as to why he has gone and that's troubled the market. There is now a guessing game as to whether Computacenter has found something lurking in the closet or there's another reason why the CFO has gone."
Market Movers
FTSE 250 - Risers
PureTech Health (PRTC) 174.40p 7.13%
W.A.G Payment Solutions (WPS) 83.00p 3.75%
Johnson Matthey (JMAT) 1,399.00p 3.48%
Moonpig Group (MOON) 228.00p 2.47%
Watches of Switzerland Group (WOSG) 589.50p 2.43%
Trustpilot Group (TRST) 301.50p 2.38%
Raspberry PI Holdings (RPI) 488.20p 2.01%
Patria Private Equity Trust (PPET) 546.00p 1.87%
Senior (SNR) 158.80p 1.79%
NCC Group (NCC) 144.00p 1.69%
FTSE 250 - Fallers
Computacenter (CCC) 2,122.00p -5.18%
SThree (STEM) 260.50p -3.52%
International Workplace Group (IWG) 157.90p -3.07%
Pennon Group (PNN) 607.00p -2.72%
Zigup (ZIG) 322.50p -2.71%
Bloomsbury Publishing (BMY) 680.00p -2.58%
HICL Infrastructure (HICL) 117.40p -2.49%
Safestore Holdings (SAFE) 671.00p -2.33%
SSP Group (SSPG) 182.00p -2.31%
Hammerson (HMSO) 281.40p -2.29%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.